期刊文献+

联合检测肺癌血清中TSGF、NSE和CYFRA21-1的临床价值 被引量:13

Clinical value of combined detection of serumTSGF,NSE and CYFRA21-1 in lung cancer
在线阅读 下载PDF
导出
摘要 目的探讨肺癌患者血清中恶性肿瘤相关物质TSGF、NSE和CYFRA21-1的水平及其临床意义。方法用电化学发光免疫法(ECLIA)检测210例肺癌患者、44例肺良性疾病患者及112例健康对照血清NSE和CYFRA21-1水平,同时用光电比色法检测其血清TSGF水平。结果与肺良性疾病组及健康对照组相比,肺癌患者血清中3项标志物的水平明显升高(P<0.05)。3项标志物的水平和敏感性与病理类型、非小细胞肺癌(NSCLC)临床分期及淋巴结转移有关(P<0.05)。TSGF、NSE及CYFRA21-1判别肺癌血清的敏感性分别为60.0%、38.1%和59.5%,特异性分别为92.9%、93.6%和96.8%,3项标志物联合检测判别肺癌血清的敏感性和特异性分别为87.6%和84.0%。治疗前及治疗后无效组患者血清3项标志物的水平均明显高于治疗后有效组(P<0.05)。结论血清TSGF、NSE及CYFRA21-1联合检测在肺癌诊断、病情监测及疗效判断方面具有较重要的临床价值,三者联合检测可明显提高肺癌诊断的敏感性。 [Objective] To detect the clinical significance of serum tumor supplies group of factors (TSGF), NSE and CYFRA21-1 in patients with lung cancer, [Methods] The serum levels of NSE, CYFRA21-1 and TSGF in 210 patients with lung cancer, 44 patients with benign lung disease and 112 healthy controls were measured by Elctrochemiluminescence immuno-assay (ECLIA) and spectrophotometry, [Results] The serum levels of TSGF,NSE and CYFRA21-1 in patients with lung cancer were significantly higher than those in benign lung disease and healthy controls (P 〈0.05), The serum levels and sensitivity of 3 tumor markers in patients with lung cancer were related to types of pathology, and the serum levels of 3 tumor markers in patients with non-small cell lung cancer were correlated significantly with clinical stage and lymph node metastasis. The sensitivity for lung cancer detection of serum TSGF, NSE and CYFRA21-1 were 60,0%, 38,1% and 59,5%, The specificity of TSGF, NSE and CYFRA21-1 were 92,9%, 93,6% and 96.8%, The sensitivity and specificity for lung cancer detection of combined detection of TSGF, NSE and CYFRA21-1 were 87,6% and 84.0%, The serum levels of 3 tumor markers for newly diagnosed cancers and non-responders were significantly higher than that for responders (P 〈0.05), [Conclusion] The combined detection of serum TSGF, NSE and CYFRA21-1 is of important clinical value in clinical diagnosis, monitor and evaluation of response to treatment of lung cancer, and the combined detection of serum TSGF, NSE and CYFRA21-1 might significantly improve the sensitivity for lung cancer detection.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第3期305-308,312,共5页 China Journal of Modern Medicine
基金 广西卫生厅自筹基金项目(No:Z2004071)
关键词 肺癌 TSGF NSE CYFRA21—1 肿瘤标志物 lung cancer TSGF NSE CYFRA21-1 tumor marker
  • 相关文献

参考文献9

二级参考文献24

  • 1郭华北,蒋秉坤.CYFRA21-1:新的非小细胞肺癌标志物[J].国外医学(临床生物化学与检验学分册),1995,16(1):8-11. 被引量:13
  • 2郭华北,蒋秉坤.血清CYFRA21-1免疫放射分析在非小细胞肺癌诊断中的临床价值[J].中国肿瘤临床,1996,23(4):236-239. 被引量:8
  • 3李蓉,李睿.肺癌肿瘤标记物研究进展[J].国外医学(肿瘤学分册),1996,23(2):98-103. 被引量:29
  • 4徐元斌 王德春 等.恶性肿瘤特异性生长因子(TSGF)测定及临床应用[J].福建医学检验,1996,1(3):118-118.
  • 5柏华 丁康生.血清肿瘤标志物对肺癌的诊断价值[J].中华肿瘤杂志,1995,17(1):23-23.
  • 6陈遂康 等.肺癌标志物的研究--血清唾液酸测定与肺癌诊断以及含量变化机量的初探[J].中华医学杂志,1981,61(2):65-65.
  • 7汪欣,福建医学检验,1997年,2卷,1期,10页
  • 8徐元斌,福建医学检验,1996年,1卷,3期,118页
  • 9柏华,血清肿瘤标志物对肺癌的诊断价值,1995年,1卷,1期,23页
  • 10汤钊猷,现代肿瘤学,1993年,87页

共引文献122

同被引文献99

引证文献13

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部